Juvenescence Ltd - 14 Mar 2023 Form 4 Insider Report for AgeX Therapeutics, Inc. (SER)

Role
Director, 10%+ Owner
Signature
/s/ Gregory Bailey, Executive Chairman of Juvenescence Ltd.
Issuer symbol
SER
Transactions as of
14 Mar 2023
Net transactions value
$0
Form type
4
Filing time
22 Mar 2023, 16:20:14 UTC
Previous filing
17 Feb 2023
Next filing
18 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGE Common Stock Gift $0 -16,447,500 -100% $0.000000* 0 14 Mar 2023 Direct F1
holding AGE Common Stock 16,447,500 14 Mar 2023 By Juvenescence US Corp. F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction involved a transfer of securities to the reporting person's wholly owned subsidiary, Juvenescence US Corp.

Remarks:

Director by deputization